1/5/10 13:01 | 12/21/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.ad | 20 | 9.09 | 4 | 2 | 29 | 10 | D | 39 | 40 | 27 | 16 | 10 | 11 | 1 | 1 | -3 | -2 | -11 | 5 | 4 | 74 |
12/23/09 09:55 | 12/21/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 20 | 9.09 | 5 | 2 | 42 | 8 | D | 37 | 52 | 32 | 19 | 12 | 11 | 10 | 1 | 0 | 0 | -8 | 6 | 10 | 72 |
11/4/09 13:16 | 11/2/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.dm | 43 | 12.96 | 5 | 3 | 185 | 5 | D | 21 | 8 | 44 | 10 | 3 | 1 | -3 | -2 | -3 | 3 | 4 | 0 | 20 | 69 |
11/4/09 13:16 | 11/2/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.dm | -103 | 31.26 | 5 | -3 | -39 | 5 | D | 21 | 8 | 44 | 10 | 3 | 1 | -3 | -2 | -3 | 3 | 4 | 0 | 20 | 69 |
7/30/09 13:59 | 7/29/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 92 | 21.59 | 5 | 4 | 522 | 5 | D | 54 | 7 | 19 | 25 | 13 | 4 | 1 | -1 | 2 | -3 | -2 | 9 | 10 | 48 |
2/4/09 12:59 | 2/3/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 39 | 12.95 | 9 | 3 | 144 | 5 | B | | | | | | | | | -1 | -3 | -31 | -19 | 10 | 20 |
2/4/09 12:59 | 2/3/09 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -80 | 26.68 | 9 | -3 | -37 | 5 | B | | | | | | | | | -1 | -3 | -31 | -19 | 10 | 20 |
11/21/08 14:24 | 11/21/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | P | 22 | 21.78 | 7 | 1 | 25 | 5 | D | 62 | -16 | -15 | -18 | -12 | -26 | -18 | -12 | -4 | 4 | 9 | 3 | 1 | 52 |
10/14/08 12:20 | 10/10/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 33 | 16.18 | 6 | 2 | 100 | 4 | D | 82 | 5 | 8 | 14 | 4 | -7 | -1 | 4 | 2 | 12 | -1 | -7 | -21 | 16 |
10/14/08 12:20 | 10/10/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -28 | 23.67 | 6 | -1 | -23 | 4 | D | 82 | 5 | 8 | 14 | 4 | -7 | -1 | 4 | 2 | 12 | -1 | -7 | -21 | 16 |
8/4/08 14:46 | 8/4/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 38 | 12.96 | 3 | 3 | 999% | 3 | D | 102 | 35 | 8 | 6 | 6 | 17 | 7 | 0 | 0 | 3 | -5 | 8 | -3 | 7 |
8/4/08 14:46 | 8/4/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -79 | 26.80 | 3 | -3 | -48 | 3 | D | 102 | 35 | 8 | 6 | 6 | 17 | 7 | 0 | 0 | 3 | -5 | 8 | -3 | 7 |
4/8/08 09:31 | 4/7/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 61 | 13.63 | 3 | 5 | | 3 | D | 79 | 69 | 8 | 5 | -1 | 12 | 13 | 2 | -2 | -9 | -6 | -17 | -2 | -20 |
4/8/08 09:31 | 4/7/08 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -125 | 27.68 | 3 | -5 | -59 | 3 | D | 79 | 69 | 8 | 5 | -1 | 12 | 13 | 2 | -2 | -9 | -6 | -17 | -2 | -20 |
10/25/07 12:35 | 10/24/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.dm | 45 | 10.91 | 3 | 4 | | 3 | D | 101 | 84 | 47 | 33 | 18 | -1 | 0 | 0 | 2 | 6 | 5 | -6 | -1 | 15 |
10/25/07 12:35 | 10/24/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.dm | -104 | 25.33 | 3 | -4 | -57 | 3 | D | 101 | 84 | 47 | 33 | 18 | -1 | 0 | 0 | 2 | 6 | 5 | -6 | -1 | 15 |
9/12/07 16:04 | 9/11/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.ad | 15 | 6.53 | 4 | 2 | 271 | 3 | D | 102 | 66 | 48 | 23 | 13 | 10 | 4 | -3 | -2 | -3 | 15 | 15 | 19 | 20 |
9/12/07 15:34 | 5/11/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 15 | 6.53 | 4 | 2 | 271 | 3 | D | 102 | 66 | 48 | 23 | 13 | 10 | 4 | -3 | -1 | -4 | 14 | 13 | 18 | 18 |
8/9/07 19:25 | 8/9/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 27 | 15.20 | 3 | 2 | | 1 | D | 87 | 57 | 33 | 20 | 6 | 3 | 8 | 2 | -1 | 3 | 9 | 27 | 24 | 32 |
8/9/07 19:25 | 8/9/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -53 | 30.49 | 3 | -2 | -76 | 1 | D | 87 | 57 | 33 | 20 | 6 | 3 | 8 | 2 | -1 | 3 | 9 | 27 | 24 | 32 |
5/11/07 17:22 | 5/11/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 53 | 15.20 | 2 | 4 | | 1 | D | 102 | 14 | 26 | 11 | 9 | 4 | 2 | 1 | 2 | 5 | 6 | 19 | 59 | 50 |
5/11/07 17:22 | 5/11/07 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -89 | 25.53 | 2 | -4 | -86 | 1 | D | 102 | 14 | 26 | 11 | 9 | 4 | 2 | 1 | 2 | 5 | 6 | 19 | 59 | 50 |
11/9/06 16:43 | 11/7/06 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 15 | 9.80 | 2 | 2 | | 1 | D | 5 | 7 | -11 | 9 | -5 | 0 | -2 | -1 | 1 | 1 | 1 | 10 | 29 | 99 |
11/9/06 16:43 | 11/7/06 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -31 | 20.35 | 2 | -2 | -73 | 1 | D | 5 | 7 | -11 | 9 | -5 | 0 | -2 | -1 | 1 | 1 | 1 | 10 | 29 | 99 |
8/23/06 08:24 | 8/21/06 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 23 | 18.72 | 1 | 1 | | 1 | D | -1 | 16 | -16 | -2 | 2 | -5 | 1 | 1 | 3 | 0 | 6 | 7 | 25 | 57 |
8/23/06 08:24 | 8/21/06 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -23 | 18.72 | 1 | -1 | -69 | 1 | D | -1 | 16 | -16 | -2 | 2 | -5 | 1 | 1 | 3 | 0 | 6 | 7 | 25 | 57 |
11/8/05 14:55 | 11/8/05 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | M.d | 56 | 10.15 | 1 | 6 | | 0 | D | 16 | 5 | 50 | 19 | 17 | 2 | 2 | 1 | -1 | 2 | 6 | 13 | 19 | 6 |
11/8/05 14:55 | 11/8/05 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | S.d | -103 | 18.80 | 1 | -6 | -94 | 0 | D | 16 | 5 | 50 | 19 | 17 | 2 | 2 | 1 | -1 | 2 | 6 | 13 | 19 | 6 |
1/12/04 12:06 | 1/8/04 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP of R, | S.dm | -81 | 20.16 | 3 | -4 | -96 | 0 | D | 51 | 73 | 37 | 36 | 22 | 6 | 6 | 0 | -1 | 0 | 2 | -14 | -8 | -3 |